101 results
Page 3 of 6
8-K
EX-99.1
d2fiq1w4ac7nbmop
14 Sep 22
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
4:01pm
8-K
EX-99.2
cv1xf9e pj
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-99.1
7ur1jv
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-10.1
5h1cmu3q
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
siqx 83uhuvk96
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
dgzsf9m
8 Jul 22
Prospectus supplement for primary offering
4:09pm
8-K
EX-99.1
6cd1 87gn
7 Jul 22
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
4:09pm
8-K
EX-99.2
me86uakxa8qlju6tw2
26 May 22
Other Events
7:02am
8-K
EX-99.1
zbik0nv709y3ls8g95tn
26 May 22
Other Events
7:02am
8-K
EX-99.1
g5mhlow9uc06efxr9aav
7 Apr 22
Nurix Therapeutics Reports Fiscal First Quarter 2022 Financial Results and Provides a Corporate Update
4:08pm
8-K
EX-99.1
kv38wtc ifo72kzyib8
27 Jan 22
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Corporate Update
4:07pm